Let Bionic News Today

Our endocrinology month in review spotlights our most popular content from December 2023. Our list of the most popular content from the past month includes the ADA Standards of Care—2024, label updates, a feature from our This Year in Medicine series, and more!

Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas ...

RTW Biotech Opportunities Ltd on Monday said its portfolio company Beta Bionics Inc has secured USD100 million in funding. RTW is a New York-based investment firm, which is focused on the life...

/PRNewswire/ -- The insulin pump market size is expected to increase by USD 5,465.96 million from 2022 to 2027, registering a CAGR of 16.25%, according to the...

Type 1 diabetes is a 24/7/365 endeavor, experts say. Ed Damiano’s breakthrough automated insulin delivery device, the iLet, could change that.

The U.S. Food and Drug Administration (FDA) has granted clearance to Beta Bionics Inc. for the company’s Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for use by people ages six years and older with type 1 diabetes.

The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for persons 6 years of age and older with type 1 diabetes.

Beta Bionics Announces FDA Clearance and Commercialization of the iLet ...

Announced by the US FDA on May 19, 2023, the clearance of the iLet ACE Pump and the iLet Dosing Decision Software, when combined with a compatible CGM, will form the iLet Bionic Pancreas.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years...